ARMATA PHARMACEUTICALS INC (ARMP) Stock News
NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD
ARMP Latest News, Press Relases and Analysis
ARMP Stock Earnings: Armata Pharmaceuticals Beats EPS for Q2 2024
ARMP stock results show that Armata Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge
Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries.
ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Armata Pharmaceuticals gets $25M in financing and new executive chief (NYSE:ARMP)
Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals (ARMP) enters...
Mentions: INVA
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday!
Armata stock surges 15% as inhaled bacterial drug shows promise in lung disorder patients
Armata Pharmaceuticals (ARMP) said its inhaled bacterial infection drug for lung disorder was well-tolerated with a treatment emergent adverse event ((TEAE)) profile similar to placebo...